| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ABL2
|
ABL proto-oncogene 2, non-receptor tyrosine kinase
|
|
ACACA
|
acetyl-CoA carboxylase alpha
|
|
ACADVL
|
acyl-CoA dehydrogenase, very long chain
|
|
ACO1
|
aconitase 1, soluble
|
|
ACTN1
|
actinin, alpha 1
|
|
ACTN4
|
actinin, alpha 4
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADD1
|
adducin 1 (alpha)
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
|
AGAP2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AKAP12
|
A kinase (PRKA) anchor protein 12
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT1S1
|
AKT1 substrate 1 (proline-rich)
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
AMPH
|
amphiphysin
|
|
APC
|
adenomatous polyposis coli
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP9
|
aquaporin 9
|
|
ARHGAP12
|
Rho GTPase activating protein 12
|
|
ARHGAP22
|
Rho GTPase activating protein 22
|
|
ARHGAP31
|
Rho GTPase activating protein 31
|
|
ARHGAP35
|
Rho GTPase activating protein 35
|
|
ARHGAP42
|
Rho GTPase activating protein 42
|
|
ARHGDIA
|
Rho GDP dissociation inhibitor (GDI) alpha
|
|
ARHGEF2
|
Rho/Rac guanine nucleotide exchange factor (GEF) 2
|
|
ARHGEF7
|
Rho guanine nucleotide exchange factor (GEF) 7
|
|
ARNTL
|
aryl hydrocarbon receptor nuclear translocator-like
|
|
ARRB1
|
arrestin, beta 1
|
|
ASGR2
|
asialoglycoprotein receptor 2
|
|
ATF1
|
activating transcription factor 1
|
|
ATF2
|
activating transcription factor 2
|
|
ATG5
|
autophagy related 5
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATR
|
ATR serine/threonine kinase
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BASP1
|
brain abundant, membrane attached signal protein 1
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCR
|
breakpoint cluster region
|
|
BECN1
|
beclin 1, autophagy related
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIK
|
BCL2-interacting killer (apoptosis-inducing)
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
BMF
|
Bcl2 modifying factor
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
CALD1
|
caldesmon 1
|
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha
|
|
CAPN2
|
calpain 2, (m/II) large subunit
|
|
CASP2
|
caspase 2, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CAV2
|
caveolin 2
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBX1
|
chromobox homolog 1
|
|
CCND1
|
cyclin D1
|
|
CCND3
|
cyclin D3
|
|
CCNE1
|
cyclin E1
|
|
CCNE2
|
cyclin E2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CDC25C
|
cell division cycle 25C
|
|
CDC6
|
cell division cycle 6
|
|
CDC7
|
cell division cycle 7
|
|
CDCA7
|
cell division cycle associated 7
|
|
CDCP1
|
CUB domain containing protein 1
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK10
|
cyclin-dependent kinase 10
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CIZ1
|
CDKN1A interacting zinc finger protein 1
|
|
CLASP2
|
cytoplasmic linker associated protein 2
|
|
CLOCK
|
clock circadian regulator
|
|
CNN3
|
calponin 3, acidic
|
|
CORO1B
|
coronin, actin binding protein, 1B
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRK
|
v-crk avian sarcoma virus CT10 oncogene homolog
|
|
CRKL
|
v-crk avian sarcoma virus CT10 oncogene homolog-like
|
|
CRY1
|
cryptochrome circadian clock 1
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSNK1E
|
casein kinase 1, epsilon
|
|
CTBP1
|
C-terminal binding protein 1
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
CTNND2
|
catenin (cadherin-associated protein), delta 2
|
|
CTTN
|
cortactin
|
|
CUX1
|
cut-like homeobox 1
|
|
DAB1
|
Dab, reelin signal transducer, homolog 1 (Drosophila)
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DAPP1
|
dual adaptor of phosphotyrosine and 3-phosphoinositides
|
|
DBNL
|
drebrin-like
|
|
DCLRE1C
|
DNA cross-link repair 1C
|
|
DDR1
|
discoidin domain receptor tyrosine kinase 1
|
|
DDX5
|
DEAD (Asp-Glu-Ala-Asp) box helicase 5
|
|
DNM1L
|
dynamin 1-like
|
|
DOK1
|
docking protein 1, 62kDa (downstream of tyrosine kinase 1)
|
|
DPYSL2
|
dihydropyrimidinase-like 2
|
|
DRD2
|
dopamine receptor D2
|
|
DUSP6
|
dual specificity phosphatase 6
|
|
DYNLT1
|
dynein, light chain, Tctex-type 1
|
|
DYRK2
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
|
EIF2AK4
|
eukaryotic translation initiation factor 2 alpha kinase 4
|
|
EIF2B5
|
eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
EIF5
|
eukaryotic translation initiation factor 5
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
ELMO1
|
engulfment and cell motility 1
|
|
ENAH
|
enabled homolog (Drosophila)
|
|
ENPP3
|
ectonucleotide pyrophosphatase/phosphodiesterase 3
|
|
EPHA3
|
EPH receptor A3
|
|
EPHA4
|
EPH receptor A4
|
|
EPHA5
|
EPH receptor A5
|
|
EPHB1
|
EPH receptor B1
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERCC3
|
excision repair cross-complementation group 3
|
|
ESR1
|
estrogen receptor 1
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
|
EVL
|
Enah/Vasp-like
|
|
EZR
|
ezrin
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
FAS
|
Fas cell surface death receptor
|
|
FBXO31
|
F-box protein 31
|
|
FER
|
fer (fps/fes related) tyrosine kinase
|
|
FGF10
|
fibroblast growth factor 10
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGFBP1
|
fibroblast growth factor binding protein 1
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FLCN
|
folliculin
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLOT2
|
flotillin 2
|
|
FLRT1
|
fibronectin leucine rich transmembrane protein 1
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXG1
|
forkhead box G1
|
|
FOXM1
|
forkhead box M1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXO4
|
forkhead box O4
|
|
FRS2
|
fibroblast growth factor receptor substrate 2
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
G3BP1
|
GTPase activating protein (SH3 domain) binding protein 1
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GAB1
|
GRB2-associated binding protein 1
|
|
GAB2
|
GRB2-associated binding protein 2
|
|
GAP43
|
growth associated protein 43
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
|
GATA4
|
GATA binding protein 4
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GLI2
|
GLI family zinc finger 2
|
|
GLP1R
|
glucagon-like peptide 1 receptor
|
|
GNB2L1
|
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1
|
|
GNG12
|
guanine nucleotide binding protein (G protein), gamma 12
|
|
GRB14
|
growth factor receptor-bound protein 14
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GRIN1
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GRIP1
|
glutamate receptor interacting protein 1
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GTF2I
|
general transcription factor IIi
|
|
GYS1
|
glycogen synthase 1 (muscle)
|
|
H2AFX
|
H2A histone family, member X
|
|
H3F3A
|
H3 histone, family 3A
|
|
H3F3B
|
H3 histone, family 3B (H3.3B)
|
|
HCK
|
HCK proto-oncogene, Src family tyrosine kinase
|
|
HCRTR1
|
hypocretin (orexin) receptor 1
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIP1
|
huntingtin interacting protein 1
|
|
HIST1H2BN
|
histone cluster 1, H2bn
|
|
HIST1H3A
|
histone cluster 1, H3a
|
|
HIST1H3B
|
histone cluster 1, H3b
|
|
HMGN1
|
high mobility group nucleosome binding domain 1
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
ID3
|
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
|
IFNAR2
|
interferon (alpha, beta and omega) receptor 2
|
|
IFNGR1
|
interferon gamma receptor 1
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2BP1
|
insulin-like growth factor 2 mRNA binding protein 1
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
INSR
|
insulin receptor
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRS1
|
insulin receptor substrate 1
|
|
IRS4
|
insulin receptor substrate 4
|
|
IRX2
|
iroquois homeobox 2
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB4
|
integrin, beta 4
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
JUND
|
jun D proto-oncogene
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
|
KDR
|
kinase insert domain receptor
|
|
KHDRBS3
|
KH domain containing, RNA binding, signal transduction associated 3
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KSR1
|
kinase suppressor of ras 1
|
|
LASP1
|
LIM and SH3 protein 1
|
|
LATS1
|
large tumor suppressor kinase 1
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LDLRAP1
|
low density lipoprotein receptor adaptor protein 1
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LIFR
|
leukemia inhibitory factor receptor alpha
|
|
LIMA1
|
LIM domain and actin binding 1
|
|
LIMK1
|
LIM domain kinase 1
|
|
LIMK2
|
LIM domain kinase 2
|
|
LPIN1
|
lipin 1
|
|
LPP
|
LIM domain containing preferred translocation partner in lipoma
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAP2
|
microtubule-associated protein 2
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAP3K11
|
mitogen-activated protein kinase kinase kinase 11
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MAPKAPK5
|
mitogen-activated protein kinase-activated protein kinase 5
|
|
MAPT
|
microtubule-associated protein tau
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCM2
|
minichromosome maintenance complex component 2
|
|
MCTS1
|
malignant T cell amplified sequence 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MEF2A
|
myocyte enhancer factor 2A
|
|
MEF2C
|
myocyte enhancer factor 2C
|
|
MEGF10
|
multiple EGF-like-domains 10
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MOS
|
v-mos Moloney murine sarcoma viral oncogene homolog
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYF6
|
myogenic factor 6 (herculin)
|
|
MYL12B
|
myosin, light chain 12B, regulatory
|
|
MYL9
|
myosin, light chain 9, regulatory
|
|
MYOD1
|
myogenic differentiation 1
|
|
NBN
|
nibrin
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCOR2
|
nuclear receptor corepressor 2
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
NFATC4
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NGEF
|
neuronal guanine nucleotide exchange factor
|
|
NMNAT1
|
nicotinamide nucleotide adenylyltransferase 1
|
|
NPAT
|
nuclear protein, ataxia-telangiectasia locus
|
|
NPHS1
|
nephrosis 1, congenital, Finnish type (nephrin)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
|
NUAK1
|
NUAK family, SNF1-like kinase, 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OSBP
|
oxysterol binding protein
|
|
PAG1
|
phosphoprotein membrane anchor with glycosphingolipid microdomains 1
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDHA1
|
pyruvate dehydrogenase (lipoamide) alpha 1
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PER2
|
period circadian clock 2
|
|
PGR
|
progesterone receptor
|
|
PHB
|
prohibitin
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PITPNA
|
phosphatidylinositol transfer protein, alpha
|
|
PITPNB
|
phosphatidylinositol transfer protein, beta
|
|
PKM
|
pyruvate kinase, muscle
|
|
PKN1
|
protein kinase N1
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific
|
|
PLD2
|
phospholipase D2
|
|
PLIN1
|
perilipin 1
|
|
PLSCR1
|
phospholipid scramblase 1
|
|
POLH
|
polymerase (DNA directed), eta
|
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPP1R12A
|
protein phosphatase 1, regulatory subunit 12A
|
|
PPP1R14A
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A
|
|
PPP1R14B
|
protein phosphatase 1, regulatory (inhibitor) subunit 14B
|
|
PPP1R2
|
protein phosphatase 1, regulatory (inhibitor) subunit 2
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKD1
|
protein kinase D1
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRKG1
|
protein kinase, cGMP-dependent, type I
|
|
PRKRA
|
protein kinase, interferon-inducible double stranded RNA dependent activator
|
|
PRL
|
prolactin
|
|
PSTPIP1
|
proline-serine-threonine phosphatase interacting protein 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGES3
|
prostaglandin E synthase 3 (cytosolic)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN12
|
protein tyrosine phosphatase, non-receptor type 12
|
|
PTPRA
|
protein tyrosine phosphatase, receptor type, A
|
|
PTPRB
|
protein tyrosine phosphatase, receptor type, B
|
|
PTPRH
|
protein tyrosine phosphatase, receptor type, H
|
|
PTPRO
|
protein tyrosine phosphatase, receptor type, O
|
|
PTS
|
6-pyruvoyltetrahydropterin synthase
|
|
PVR
|
poliovirus receptor
|
|
PXN
|
paxillin
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD17
|
RAD17 homolog (S. pombe)
|
|
RAD9A
|
RAD9 homolog A (S. pombe)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RANBP3
|
RAN binding protein 3
|
|
RAPH1
|
Ras association (RalGDS/AF-6) and pleckstrin homology domains 1
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
|
RASGRF1
|
Ras protein-specific guanine nucleotide-releasing factor 1
|
|
RB1
|
retinoblastoma 1
|
|
RCAN1
|
regulator of calcineurin 1
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RET
|
ret proto-oncogene
|
|
RHEB
|
Ras homolog enriched in brain
|
|
RICTOR
|
RPTOR independent companion of MTOR, complex 2
|
|
RIN1
|
Ras and Rab interactor 1
|
|
ROCK2
|
Rho-associated, coiled-coil containing protein kinase 2
|
|
RPA2
|
replication protein A2, 32kDa
|
|
RPS6
|
ribosomal protein S6
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3
|
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RTKN
|
rhotekin
|
|
RTN4
|
reticulon 4
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX2
|
runt-related transcription factor 2
|
|
S100A11
|
S100 calcium binding protein A11
|
|
SCN1B
|
sodium channel, voltage gated, type I beta subunit
|
|
SCRIB
|
scribbled planar cell polarity protein
|
|
SDC4
|
syndecan 4
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SGK2
|
serum/glucocorticoid regulated kinase 2
|
|
SGK3
|
serum/glucocorticoid regulated kinase family, member 3
|
|
SGOL1
|
shugoshin-like 1 (S. pombe)
|
|
SH3GL1
|
SH3-domain GRB2-like 1
|
|
SH3PXD2A
|
SH3 and PX domains 2A
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SIAH1
|
siah E3 ubiquitin protein ligase 1
|
|
SIAH2
|
siah E3 ubiquitin protein ligase 2
|
|
SKAP2
|
src kinase associated phosphoprotein 2
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SLC9A3
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3
|
|
SLK
|
STE20-like kinase
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SMARCD3
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3
|
|
SMC1A
|
structural maintenance of chromosomes 1A
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
|
SRSF5
|
serine/arginine-rich splicing factor 5
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT2
|
signal transducer and activator of transcription 2, 113kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STIP1
|
stress-induced phosphoprotein 1
|
|
STK3
|
serine/threonine kinase 3
|
|
STK4
|
serine/threonine kinase 4
|
|
STMN1
|
stathmin 1
|
|
SYN2
|
synapsin II
|
|
TAB1
|
TGF-beta activated kinase 1/MAP3K7 binding protein 1
|
|
TAB2
|
TGF-beta activated kinase 1/MAP3K7 binding protein 2
|
|
TAB3
|
TGF-beta activated kinase 1/MAP3K7 binding protein 3
|
|
TAX1BP1
|
Tax1 (human T-cell leukemia virus type I) binding protein 1
|
|
TCF3
|
transcription factor 3
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFCP2
|
transcription factor CP2
|
|
TFEB
|
transcription factor EB
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TFRC
|
transferrin receptor
|
|
TGFB1I1
|
transforming growth factor beta 1 induced transcript 1
|
|
TGM2
|
transglutaminase 2
|
|
TICAM2
|
toll-like receptor adaptor molecule 2
|
|
TJP1
|
tight junction protein 1
|
|
TK1
|
thymidine kinase 1, soluble
|
|
TOPBP1
|
topoisomerase (DNA) II binding protein 1
|
|
TP53
|
tumor protein p53
|
|
TP53BP1
|
tumor protein p53 binding protein 1
|
|
TRIM28
|
tripartite motif containing 28
|
|
TRIP6
|
thyroid hormone receptor interactor 6
|
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TTK
|
TTK protein kinase
|
|
TXN
|
thioredoxin
|
|
UBTF
|
upstream binding transcription factor, RNA polymerase I
|
|
UBXN1
|
UBX domain protein 1
|
|
USP28
|
ubiquitin specific peptidase 28
|
|
VANGL2
|
VANGL planar cell polarity protein 2
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
VAV3
|
vav 3 guanine nucleotide exchange factor
|
|
VCL
|
vinculin
|
|
VIM
|
vimentin
|
|
WASF2
|
WAS protein family, member 2
|
|
WASL
|
Wiskott-Aldrich syndrome-like
|
|
WT1
|
Wilms tumor 1
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XBP1
|
X-box binding protein 1
|
|
XPA
|
xeroderma pigmentosum, complementation group A
|
|
YAP1
|
Yes-associated protein 1
|
|
YBX1
|
Y box binding protein 1
|
|
YWHAB
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta
|
|
YWHAH
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
|
ZC3HC1
|
zinc finger, C3HC-type containing 1
|
|
ZFP36
|
ZFP36 ring finger protein
|
